Literature DB >> 9009137

Cholestatic jaundice induced by ciprofloxacin.

J K Labowitz1, W B Silverman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9009137     DOI： 10.1023/a:1018870029216

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.487


× No keyword cloud information.
  5 in total

1.  Fulminant hepatic failure possibly related to ciprofloxacin.

Authors:  B K Grassmick; V T Lehr; A S Sundareson
Journal:  Ann Pharmacother       Date:  1992-05       Impact factor: 3.154

2.  Fatal hepatic failure associated with ciprofloxacin.

Authors:  S Fuchs; Z Simon; M Brezis
Journal:  Lancet       Date:  1994-03-19       Impact factor: 79.321

3.  Possible ciprofloxacin-induced acute cholestatic jaundice.

Authors:  O Sherman; J L Beizer
Journal:  Ann Pharmacother       Date:  1994-10       Impact factor: 3.154

Review 4.  Review article: drug-induced hepatotoxicity.

Authors:  W M Lee
Journal:  Aliment Pharmacol Ther       Date:  1993-10       Impact factor: 8.171

5.  Suspected ciprofloxacin-induced hepatotoxicity.

Authors:  J P Villeneuve; C Davies; J Côté
Journal:  Ann Pharmacother       Date:  1995-03       Impact factor: 3.154
  5 in total
  6 in total

1.  Clinical and histopathologic features of fluoroquinolone-induced liver injury.

Authors:  Eric S Orman; Hari S Conjeevaram; Raj Vuppalanchi; James W Freston; James Rochon; David E Kleiner; Paul H Hayashi
Journal:  Clin Gastroenterol Hepatol       Date:  2011-02-26       Impact factor: 11.382

Review 2.  Hepatotoxicity Related to Anti-tuberculosis Drugs: Mechanisms and Management.

Authors:  Vidyasagar Ramappa; Guruprasad P Aithal
Journal:  J Clin Exp Hepatol       Date:  2012-12-20

Review 3.  Comparative tolerability of the newer fluoroquinolone antibacterials.

Authors:  P Ball; L Mandell; Y Niki; G Tillotson
Journal:  Drug Saf       Date:  1999-11       Impact factor: 5.606

4.  Profiles of hepatic and dysrhythmic cardiovascular events following use of fluoroquinolone antibacterials: experience from large cohorts from the Drug Safety Research Unit Prescription-Event Monitoring database.

Authors:  D W Clark; D Layton; L V Wilton; G L Pearce; S A Shakir
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

Review 5.  Ciprofloxacin-induced acute liver injury: case report and review of literature.

Authors:  Annette Zimpfer; Albert Propst; Gregor Mikuz; Wolfgang Vogel; Luigi Terracciano; Sylvia Stadlmann
Journal:  Virchows Arch       Date:  2004-01       Impact factor: 4.064

Review 6.  Idiosyncratic Drug-Induced Liver Injury Due to Ciprofloxacin: A Report of Two Cases and Review of the Literature.

Authors:  Milan Radovanovic; Tetyana Dushenkovska; Ivan Cvorovic; Natasa Radovanovic; Vimala Ramasamy; Katarina Milosavljevic; Jelena Surla; Mladen Jecmenica; Miroslav Radulovic; Tamara Milovanovic; Igor Dumic
Journal:  Am J Case Rep       Date:  2018-09-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.